ArticleFrontiers in pharmacology2022

Interleukin-6 Receptor Blockade can Increase the Risk of Nonalcoholic Fatty Liver Disease: Indications From Mendelian Randomization.

Shuxuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.